Sana Biotechnology SANA Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's retained earnings?
- Sana Biotechnology (SANA) reported retained earnings of -$1.9B in Q1 2026.
- How has Sana Biotechnology's retained earnings changed year-over-year?
- Sana Biotechnology's retained earnings decreased by 14.6% year-over-year, from -$1.65B to -$1.9B.
- What is the long-term trend for Sana Biotechnology's retained earnings?
- Over 5 years (2020 to 2025), Sana Biotechnology's retained earnings has grown at a 33.9% compound annual growth rate (CAGR), from -$429.43M to -$1.85B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.